List view / Grid view

Lonza

Filter the results

 

news

Stem cells: from bench to drug development

6 August 2014 | By

Working in stem cell research can be both immensely rewarding and notoriously challenging. One of the most prominent challenges is taking what are often exciting new advances in stem cell biology made in the research lab, and translating these into viable, impactful therapies for patients.

news

Lonza awarded contract to generate clinical grade iPSCs by the NIH CRM

10 October 2012 | By

The National Institutes of Health Center for Regenerative Medicine (NIH CRM) has awarded Lonza Walkersville, Inc. a contract to generate induced pluripotent stem cells (iPSCs) under current Good Manufacturing Practices (cGMP). The production of clinical grade iPSCs is considered a critical component to realizing the therapeutic potential of pluripotent stem…